These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 17380097

  • 1. Validated image fusion of dedicated PET and CT for external beam radiation and therapy in the head and neck area.
    Vogel WV, Schinagl DA, Van Dalen JA, Kaanders JH, Oyen WJ.
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):74-83. PubMed ID: 17380097
    [Abstract] [Full Text] [Related]

  • 2. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
    Deantonio L, Beldì D, Gambaro G, Loi G, Brambilla M, Inglese E, Krengli M.
    Radiat Oncol; 2008 Sep 18; 3():29. PubMed ID: 18801181
    [Abstract] [Full Text] [Related]

  • 3. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care.
    Gordin A, Golz A, Keidar Z, Daitzchman M, Bar-Shalom R, Israel O.
    Otolaryngol Head Neck Surg; 2007 Jul 18; 137(1):130-7. PubMed ID: 17599580
    [Abstract] [Full Text] [Related]

  • 4. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck.
    Zimmer LA, Branstetter BF, Nayak JV, Johnson JT.
    Laryngoscope; 2005 Nov 18; 115(11):2029-34. PubMed ID: 16319618
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA.
    J Nucl Med; 2009 Aug 18; 50(8):1205-13. PubMed ID: 19617339
    [Abstract] [Full Text] [Related]

  • 7. Automatic registration of PET and CT studies for clinical use in thoracic and abdominal conformal radiotherapy.
    Rizzo G, Castiglioni I, Arienti R, Cattaneo GM, Landoni C, Artioli D, Gilardi MC, Messa C, Reni M, Ceresoli GL, Fazio F.
    Q J Nucl Med Mol Imaging; 2005 Sep 18; 49(3):267-79. PubMed ID: 16172573
    [Abstract] [Full Text] [Related]

  • 8. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H, Fury M, Lee N, Kraus D.
    J Nucl Med; 2009 May 18; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [Abstract] [Full Text] [Related]

  • 9. Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer.
    Macmanus M, D'Costa I, Everitt S, Andrews J, Ackerly T, Binns D, Lau E, Ball D, Weih L, Hicks RJ.
    Australas Radiol; 2007 Aug 18; 51(4):386-93. PubMed ID: 17635480
    [Abstract] [Full Text] [Related]

  • 10. Positron emission tomography/computed tomography for staging and restaging of head and neck cancer: comparison with positron emission tomography read together with contrast-enhanced computed tomography.
    Goerres GW, Schuknecht B, Schmid DT, Stoeckli SJ, Hany TF.
    Clin Imaging; 2008 Aug 18; 32(6):431-7. PubMed ID: 19006770
    [Abstract] [Full Text] [Related]

  • 11. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
    Gourin CG, Boyce BJ, Williams HT, Herdman AV, Bilodeau PA, Coleman TA.
    Laryngoscope; 2009 Nov 18; 119(11):2150-5. PubMed ID: 19544378
    [Abstract] [Full Text] [Related]

  • 12. Influence of F-fluorodeoxyglucose-positron emission tomography on computed tomography-based radiation treatment planning for oesophageal cancer.
    Everitt C, Leong T.
    Australas Radiol; 2006 Jun 18; 50(3):271-4. PubMed ID: 16732830
    [Abstract] [Full Text] [Related]

  • 13. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
    Scarfone C, Lavely WC, Cmelak AJ, Delbeke D, Martin WH, Billheimer D, Hallahan DE.
    J Nucl Med; 2004 Apr 18; 45(4):543-52. PubMed ID: 15073248
    [Abstract] [Full Text] [Related]

  • 14. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
    Tan A, Adelstein DJ, Rybicki LA, Saxton JP, Esclamado RM, Wood BG, Lorenz RR, Strome M, Carroll MA.
    Arch Otolaryngol Head Neck Surg; 2007 May 18; 133(5):435-40. PubMed ID: 17515501
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endotracheal metastasis from squamous cell cancer of the head and neck: PET/CT imaging.
    Nguyen BD, Ram PC, Roarke MC.
    Clin Nucl Med; 2008 May 18; 33(5):340-1. PubMed ID: 18431150
    [Abstract] [Full Text] [Related]

  • 17. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
    Quon A, Fischbein NJ, McDougall IR, Le QT, Loo BW, Pinto H, Kaplan MJ.
    J Nucl Med; 2007 Jan 18; 48 Suppl 1():58S-67S. PubMed ID: 17204721
    [Abstract] [Full Text] [Related]

  • 18. [FDG-PET-CT based imaging of retropharyngeal lymph nodes with its impact on radiotherapy].
    Dietl B, Marienhagen J, Murthum T, Kölbl O.
    Laryngorhinootologie; 2008 Jan 18; 87(1):39-42. PubMed ID: 17638170
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic performance of response assessment FDG-PET/CT in patients with head and neck squamous cell carcinoma treated with high-precision definitive (chemo)radiation.
    Gupta T, Jain S, Agarwal JP, Rangarajan V, Purandare N, Ghosh-Laskar S, Dinshaw KA.
    Radiother Oncol; 2010 Nov 18; 97(2):194-9. PubMed ID: 20627432
    [Abstract] [Full Text] [Related]

  • 20. Correction of an image size difference between positron emission tomography (PET) and computed tomography (CT) improves image fusion of dedicated PET and CT.
    Vogel WV, van Dalen JA, Schinagl DA, Kaanders JH, Huisman H, Corstens FH, Oyen WJ.
    Nucl Med Commun; 2006 Jun 18; 27(6):515-9. PubMed ID: 16710106
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.